We will happily help you address any related inquires. Please fill in the below form and submit your inquiry.

Your details were sent successfully!

Address 1

Jacqueline Postma, Ph.D.
Grant manager LUDC
Project manager IMI-SUMMIT

Lund University Diabetes Centre
CRC, Malmö University Hospital
Jan Waldenströms gata 35
SE-205 02 Malmö, Sweden
Tel: +46 (0)40 391236
Fax: +46 (0)40 391222
mailto: jacqueline.postma@med.lu.se

Address 2

Dr. Markus Albertini

Project Manager IMI-SUMMIT

Boehringer Ingelheim Pharma GmbH & Co. KG
Div. Research Germany
Tel.: +49 (7351) 54-97371
Fax: +49 (7351) 83-97371
mailto: summit@boehringer-ingelheim.com



Social Links

  • w-facebook
  • Twitter Clean
  • w-googleplus

facebook

twitter

google +

Contact Us

MISSION

To DISCOVER, DEVELOP and QUALIFY potential MARKERS that empower:

  • the identification of patients at high risk of diabetes complications

  • the monitoring of the complications' progression and patients‘ response to therapy 

To use the discovered markers as SURROGATE ENDPOINTS in clinical trials.



Thereby, SHORTEN the long lasting CLINICAL TRIALS to bring about EARLIER availability of NEW THERAPY to diabetic patients.

Related Sites